Ads
related to: SARS-CoV-2 and Respiratory Syncytial Virus
Search results
COVID Infection Not Linked to New Asthma Diagnoses in Kids
MedPage Today· 2 weeks agoA positive polymerase chain reaction (PCR) result for SARS-CoV-2 was not associated with a new...
Moderna To Present Respiratory & Cytomegalovirus Research at the ESCMID Global Congress
Digital Journal· 17 hours ago...April 29 - 17:30 (Hall I) Presenter: Mieke Soens Respiratory Syncytial Virus (RSV) OS102: Coadministration of a respiratory syncytial virus vaccine (mRNA-1345) with an influenza or SARS-CoV-2 vaccine in older adults 1-hour Oral Session, Monday, April 29 - 11:00 (Hall C) Presenter: Jaya Goswami...
Safety Concerns Put a Stop to Maternal RSV Vaccine Study
Journal of the American Medical Association· 2 weeks agoA vaccine given during pregnancy that prevents respiratory syncytial virus (RSV) in infants was about 66% effective at protecting against ...
Advancing RSV surveillance and disease burden as part of an expanded Global Influenza Surveillance...
World Health Organization· 1 week agoRespiratory Syncytial Virus (RSV) is a significant cause of acute lower respiratory infections and a leading cause ...
EXCLUSIVE: Virax Biolabs Launches Immune Profiling Solutions To Evaluate Adaptive Immunity In...
Benzinga via Yahoo Finance· 14 hours agoThursday, Virax Biolabs Group Limited (NASDAQ: VRAX) announced it is launching ‘ImmuneSelect' within...
Cardiac Events Common in Older, Hospitalized RSV Patients
MedPage Today· 2 weeks agoNew RSV vaccines could reduce risk, researchers said
Immunologist receives biomedical research award | Cornell Chronicle
Cornell News Service· 21 hours agoThe award provides $100,000 direct cost support per year for three years and designation as a...
New Products Posted to GenomeWeb: SpeeDx, Vizgen, Dovetail Genomics, Meridian Bioscience, More
GenomeWeb News· 2 weeks agoNew products and services recently posted on GenomeWeb.
CureVac (NASDAQ:CVAC) Shares Gap Up to $2.44
ETF DAILY NEWS· 2 days agoCureVac (NASDAQ:CVAC – Get Free Report) shares gapped up prior to trading on Monday . The stock had previously closed at $2.44, but opened at $2.51. CureVac shares last traded at $2.49, with ...
